Status:
UNKNOWN
The Sensitivity of Traditional Chinese Medical Diagnostic Tools for Diabetic Retinopathy Diabetic retinopathy-a Pilot Study
Lead Sponsor:
China Medical University Hospital
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
20-80 years
Brief Summary
Diabetic retinopathy (DR) is the leading cause of impaired visual function and blindness in adults. The fundus photographs were examined to detect DR. The DR severity was graded non-proliferative diab...
Eligibility Criteria
Inclusion
- type 2 DM group were diagnosed with DM based on criteria recommended by the American Diabetes Association and required to have a fasting plasma glucose of ≥7mmol/L or an HbA1c of ≥6.5%, as measured on 2 separate occasions.
Exclusion
- cancer, active liver disease, current pregnancy, active infection, and cerebrovascular disease
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 10 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04030611
Start Date
January 1 2019
End Date
October 10 2019
Last Update
July 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan, 40402